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The y3-subunit of the GABA,-receptor in rat brain has been identified by molecular cloning. When co-expressed with the aS- and @2-subunits 
in transfected cells a high potency for GA% (K, = 4.9 + I .2 pM; n?d a strong cooperativity in gating the channel (II = 1.9 t 0.2) was observed. 
The GABA response was potentiated in the presence of flunitrazepam and reduced by&CM. An analogous bi-directional modulation of the GABA 
response was observed with diazepam nnd DMCM as tested with the subunit combinations alg2y.t and a3@Zy3 expressed in Xcnoprts oocyles. 
Since the benzodiazepine receptor ligands were virtually inactive in the absence of the y3-subunit, ali tested with the a3/32- and a5/J2+ubunit 
combinations. the y3-subunit is a prcrcquisite for the benzodiazepine receptor sensitivity of the expressed GABA,-receptors. The y3-subunit could 
functionally replace the y2-subunit with regard to the bi-directional allosteric drug modulation. 
GABA,-receptor heterogeneity; Recombinant GABA,-receptor; y3-Subunit expression 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The GABA,-receptor. which mediates the main inhi- 
bitory synaptic event in the CNS, is a gated chloride 
channel whose function is modulated by various clini- 
cally important drugs, in particular by barbiturates and 
ligands of the benzodiazepine receptor. Structurally, the 
GABA,-receptor is a hetero-oligomeric protein which 
is made up, in unknown stoichiometry, of the members 
of at least 5 different classes of subunits [l-4]. The 
yt-subunit is of special relevance for the pharmacology 
of the GABAA-receptor since this subunit, in combina- 
tion with CI- and /3+ubunits, is necessary to convey ben- 
zodiazepine receptor sensitivity to recombinant 
GABA,-receptors [5]. The pattern of expression of the 
y2-subunit, mapped in the brain by in situ hybridization 
histochemistry [5-71 and by immunocytochemistry [8], 
revealed a marked regional variation suggesting that 
subunits other than the yt-subunit may exist which con- 
fer the benzodiazepine receptor sensitivity to GABA,- 
receptors. We now show that the recently identified 
y3-subunit [9] is able to convey benzodiazepine receptor 
sensitivity to GABA,-receptors when co-expressed with 
c1- and P-subunits. 
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2. I. Molecrrlm cloning 
A cDNA-library in LZap II (Stratagene) from mRNA of newborn 
rat brain was screened [IO] with 2 oligonucleotidcs derived from the 
mouse y3-subunit sequence, bp6l-26and bp 1190-I 131[9]. Oneclone 
which hybridized to both probes was isolated and the cDNA-insert 
subcloned into the Bcrr~rHI site of a pBC expression vector [I 11. The 
y3-subunit cDNA was sequenced by the dideoxynucleotide chain- 
termination method [lo]. 
2.2. El~ctroplt~~siolugicol cmcri_vsis 
Recordings were performed 24 days after transfection of human 
embryonic kidney cells (ATCC CRL 1573, 293) with rat subunit 
cDNAs using the whole-cell configuration of the patch-clamp techni- 
que [I 21 at -30 mV as described previously [I 11. Expression of cRNAs 
and clectrophysiological analysis of drug effects on GABA currents 
expressed in Xenop~.s oocytcs were performed as described previously 
v31. 
3. RESULTS 
3.1. Cloning of’ rhe rut y3-subunit cDNA 
Since the a- and P-subunit cDNAs used in the present 
study were of rat origin [13,14], the y3-subunit cDNA 
was cloned from the same species by hybridization 
screening using 2 oligonucleotide probes from the 
mouse y3-subunit cDNA sequence [9]. A 1.9 kb rat 
cDNA clone, which hybridized with both probes, con- 
tai.:cd th: entire open reading frame displaying a nu- 
cleotide and protein sequence identity of 96 and 99%, 
respectively, to the mouse cDNA clone (Fig. 1). 
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Fig. I. cDNA scquencc and dcduccd amino acid sequcncc of the y3-subunit of the GABA,,-reccplor from ral brain. The putative signal scquoncc 
clcavagc site is indicated by an arrow; sites for N-linked glycosylation arc circled: the 2 cystcincs thought lo form R disullidc bridge arc boxed in: 
the proposed membr;tnc spanning domaina (MI-Ma) arc indicated by solid lines: thcamino acids which differ from those of the mouse y.l-subunir 
scqucncc [9] arc underlined. 
The dose-response curve for GABA was generated 
by applying increasing concentrations of GABA (1. 3. 
10. 30. IOOpM) for 2 s followed by a resting interval of 
1 min to mammalian cells transfected with the a5pZy3- 
subunit cDNAs (Fig. 2). The peak amplitudes of the 
GABA-induced currents were measured and fitted sepu- 
rately for each cell with the logistic equation 
In the presence of pentobarbital (50 PM) the GABA- 
induced current (3 PM GABA) was increased by 47 + 
13% in cells transfected with the a5P2y3-subunit 
cDNAs (II = 3). This potcntiation was not dependent on 
the presence of the y3-subunit. since the GABA-rc- 
sponsc was likewise potentiated (by 106%. II = 2) in cells 
co-transfected only with the a5- and the /32-subunit 
cDNAs. To determine whether the recombinant recep- 
tors expressed from the a5/?2y3 cDNAs displayed sensi- 
tivity to benzodiazcpinc receptor ligimds. the influence 
of the agonist flunitrazepam and the inverse agonist 
PCCM (methyl-4-cthyl-j3-carbolinc-3-carbo~yl~~tc) on 
the GABA-rcsponsc was tested. Drug concentrations 
wcrc chosen which wcrc previously shown to induct a 
maximum rcsponsc in recombinant rcccptors [ 1 I. 151. In 
the prcscncc of flunitrazcpam (1 ,uM) the current indu- 
ccd by GABA (3 PM) was potcntiatcd by 86 t 12% (n 
I/J,,;,, = I/{ I + (EC,&GABA})“} (1) 
whcrc ECS,, is the GABA concentration eliciting the half 
maximal current (l/2 I,,;,,) and I1 the Hill cocfficicnt. 
The results from 4 cxpcrimcnts yicldcd villucs of EC$, 
= 4.9 + 1.2 //M und N = I.9 & 0.2. 
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Fig. 2. GABA dose-response curve of cells cc-transfccted with the a5/32y3-subunit cDNAs. (A) Superimposed whole cell currents cvokcd by 
different GABA concentrations indicated by the numbers (L(M) at each trace. (B) Plot of the relative current amplitude as a function of increasing 
GABA concentrations. The points represent mean values with standard deviations from 4 cells. 
= 3) at the &5j?2y3-receptors. The inverse agonist 
PCCM (1 PM) decreased the current amplitude elicited 
by GABA (10 PM) by 29 k 5% (n = 5) in the u@2y3- 
combination (Fig. 3). Only negligible drug modulation 
was observed in the absence of the y3-subunit. When 
the a5b2-subunit cDNAs were expressed only a slight 
reduction of the GABA response was recorded in the 
presence of flunitrazepam (1 PM) or/KCM (1 PM), by 
8 2 5% (/I = 3) and 3 k 4% (12 = 4) respectively. 
The effects of agonists and inverse agonists were 
further tested on various other subunit combinations 
containing the y3-subunit in the Xerzoplcs oocyte expres- 
sion system and compared to subunit combinations 
containing the y2 instead of the y3-subunit (Fig. 4). In 
all combinations tested the y3-subunit could function- 
ally replace the y2-subunit with regard to the positive 
allosteric modulation of the GABA response by the 
benzodiazepine agonist diazepam and the negative al- 
losteric modulation by the inverse agonist DMCM 
(methyl-4-ethyl-6, 7-dimethoxy-@-carboline-3-carboxyl- 
ate) (Fig. 4). The depression of the GABA-gated current 
by DMCM was even more pronounced in the subunit 
A. GABA + f?rCCM B. GABA + FZP 
Fig. 3. Effects of flunitrazcpam and /KCM on GABA-induced cur- 
rents in cells co-transfcctcd with the aSP2y.7~subunit cDNAs. (A) The 
GAUA-induced current (IO PM. bottom tract) was rcduccd in the 
prcscncc ofDCCM (I PM. top tract).(B) Flunitrazcpam (FZP, I PM) 
potcntiatsd (bottom tract) the current clicitcd by GABA (3pM) alone 
(top trace), 
combinations containing y3 rather than 72. When a3j32 
was expressed in the absence of a y-subunit the stimula- 
tion by diazepam was reduced to 7 It: 1% (n = 5) as 
compared to rl 10% in the presence of either y2 or 73, 
while the inhibition by DMCM was lost completely 
(Fig. 4)Jn the combinations containing the y2-subunit 
(olIp2y2, a3bZy2) the effect of diazepam was somewhat 
smaller than found previously [ 131. 
4. DISCUSSION 
Three types of y-subunits of the GABA,-receptor 
have so far been cloned [5,9,16]. The yl-subunit has 
been reported to give rise to an untypical pharmacology 
in that the recombinant receptors displayed agonistic 
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Fig. 4. Diazcpam and DMCM modulation ofdiffcrcnt subunit combi- 
nations cxprcsscd in X~~w~rr.v oocytes. Drug cffccts wcrc tcstcd at a 
GABA concentration eliciting about 10% of the maximal current 
amplitude in the rcspcctivc subunit combinations. Each value is an 
avcragc and SD of at Icast 7 cells originating from 2 diffcrcnt donor 
animals, cxccpt for the a$32 combination, for which 5 cells from a 
singlcdonorwcrcanalyscd. Thcdiazcpamconccntration was I PM; the 
DMCM concentration was 0. I PM and 0.3 /rM for the subunit com- 
binations comainiug a3 and ~1. rcspcctivcly. 
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p-subunit combinations [ 17,181. In contrast, the yZsub- 
unit conveyed a bi-directional modulation of the GABA 
response? being enhanced by an agonist and reduced by 
an inverse agonist of the benzodiazepine receptor [5]. 
This ability of the yZsubunit is shared by the y3-sub- 
unit [9] as now shown by an analysis of the a5JI2y3- 
subunit combination expressed in mammalian cells 
from rat subunit cDNAs. These findings are sub- 
stantiated by an investigation of additional subunit 
combinations (~1182~3, a3/32y3) expressed in Xc~opus 
oocytes, using a different benzodiazepine agonist and 
inverse agonist. As shown in transfected cells and in the 
oocyte expression system, neither benzodiazepine ago- 
nists nor inverse agonists appreciably modulate the 
GABA response when only the tx5/32 or the a3p3 sub- 
units, respectively, are co-expressed. This suggests that 
the y2- or y3-subunits are essential for a functional 
benzodiazepine receptor site in the triple subunit combi- 
nations. 
Both the y2- and y3-subunits support a strong coope- 
rativity of GABA in gating the channel. This is shown 
by the Hill coefficients of H = 1.9 -C 0.2 recorded for the 
cl5/?2y3-subunit combination and N = 1.7 k 0.1 report- 
ed earlier for the aS/32y2-combination [13]. However, 
the y2- and the y3-subunits may confer a different 
GABA-sensitivity to recombinant receptors. While a 
half-maximal response to GABA was obtained at a &- 
value of 4.9 k 1.2 ,uM for the a5B2y3-subunit combi- 
nation. a K, value of 14 f 3 ,uM was reported for the 
aSp2y2-subunit combination expressed in Xenopus oo- 
cytes [13]. Preliminary analysis of GABA dose-re- 
sponse curves of the subunit combinations alp2y2. 
ala2y3, a3B2y2 and a3P2y3 expressed in Xenoylrs oo- 
cytes indicates that y3 confers a 3-4-fold higher GABA- 
sensitivity to the recombinant GABA,-receptors than 
the y2-subunit (SK., unpublished observations). Thus. 
it is conceivable that the y3-subunit gives rise to recep- 
tars in situ with a higher sensitivity to GABA than those 
containing the y2-subunit. 
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